About US
Contact us
-
AstraZeneca in Discovery Pact with Cellular DynamicsCellular Dynamics International, Inc. (CDI) entered a Center of Excellence agreement with AstraZeneca to accelerate drug discovery efforts using human induced pluripotent stem cell (iPSC) lines and t2013/1/6
-
AbbVie Launches New Biopharma CompanyAbbVie has launched as an independent biopharmaceutical company, as Abbott completed the separation from the research arm of its pharmaceutical business. AbbVie launches with an estimated $18 billion2013/1/6
-
India set to rule in Novartis patent caseIndia's Supreme Court is expected to rule soon on a patent for Novartis' ($NVS) groundbreaking cancer treatment Gleevec, and Big Pharma and international aid groups are waiting with bated breath to s2013/1/5
-
Much goes into pricing a drug at $295,000So what goes into landing on $295,000 as the annual cost of a drug that maybe only 3,000 patients a year will use? That is the price tag that NPS Pharmaceuticals ($NPSP) has put on the recently appro2013/1/5
-
Lilly first to defend against DES litigationFifty to 80 years ago, the synthetic estrogen DES was commonly prescribed to women who were at risk for miscarriage and premature births. Now dozens of their daughters who have developed breast cance2013/1/4
-
Study ties drug shortages to cancer relapsesDrug shortages have been of grave concern to cancer patients for whom the right drugs can be a matter of life or death. Now there is a published study that documents that a drug shortage can effect l2013/1/4
-
Japan OKs warfarin alternative Eliquis from BMS, PfizerBristol-Myers Squibb ($BMY) and Pfizer ($PFE), which have yet to get their blood thinner Eliquis approved in the U.S., have gotten a third regulatory nod elsewhere. Japan approved the warfarin alte2012/12/27
-
Amgen licenses exclusive right to use ImmunoGen TAP technologyGlobal biotech company Amgen has licensed the exclusive right to use ImmunoGen's Targeted Antibody Payload (TAP) technology to develop anti-cancer therapies. It has already used the technology to deve2012/12/27
-
Sanofi animal health deal puts it in IndiaSanofi ($SNY) has found something to like about its prospects in India besides the country's huge population of potential drug consumers. The country also has a lot of livestock and that need drugs, t2012/12/21
-
GSK reaches $150M deal in Flonase antitrust caseGlaxoSmithKline ($GSK) and a group of drug wholesalers have come to terms in a lawsuit over generic Flonase. The drugmaker agreed to pay $150 million to the companies--including Meijer, AmerisourceBer2012/12/21